Home » Topics » Regulatory » Patents

Patents
RSS

Protease inhibitors described by Shionogi

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Toyama reveals anti-HIV quinolones

Aug. 30, 1996

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996

Antifungal agents from Hokko Kagaku

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...